Confluent cofounder says believing in AI's upside means reckoning with its 'dark side'
Confluent's cofounder wrote on X that AI fears can't be dismissed as a marketing ploy. He's said he's confident in AI.
CFLT - Confluent, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$28.64
DETAILS
HIGH:
$32.00
LOW:
$21.00
MEDIAN:
$30.50
CONSENSUS:
$28.64
DOWNSIDE:
7.58%
Stock News
Confluent Health Launches The Pain Perspective, Revealing a New National Portrait of Chronic Pain in America
LOUISVILLE, Ky. -- June 16, 2026, June 16, 2026 (GLOBE NEWSWIRE) -- Chronic pain is shaping how millions of Americans live, move, sleep, work, and recover. New findings from Confluent Health suggest the healthcare system may still be falling short in addressing it.
Confluent Makes It Easier to Build and Secure Real-Time AI at Scale
LONDON--(BUSINESS WIRE)--Confluent, an IBM Company and the data streaming pioneer, today announced new capabilities in Confluent Intelligence and Confluent Cloud that streamline how real-time artificial intelligence (AI) applications are built and secured. These updates remove the security and complexity barriers that stop organizations from moving AI workloads into the real world: Confluent unifies the AI life cycle with tools that developers already live in, integrating Apache Flink® pipeline.
Confluent Medical Technologies Names Tom Testa as Chief Operating Officer
SCOTTSDALE, Ariz., May 01, 2026 (GLOBE NEWSWIRE) -- Confluent Medical Technologies, Inc. (“Confluent”), a leading medical device and materials science contract manufacturer specializing in Nitinol and polymer components, today announced that Tom Testa, has been appointed as Chief Operating Officer ("COO") for the company, effective April 29th, 2026.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Confluent, Inc. – CFLT
NEW YORK, April 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. (“Confluent” or the “Company”) (NASDAQ: CFLT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Confluent, Inc. - CFLT
NEW YORK, April 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. ("Confluent" or the "Company") (NASDAQ: CFLT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Confluent, Inc. - CFLT
NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. (“Confluent” or the “Company”) (NASDAQ: CFLT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
IBM set for in-line Q1 as Confluent deal boosts outlook
International Business Machines Corp (NYSE:IBM) is expected to report first-quarter results largely in line with forecasts on April 22, but Bank of America is adjusting estimates following the earlier-than-expected closing of its Confluent acquisition The bank said it anticipates an “inline quarter,” with recently acquired Confluent contributing roughly $50 million in revenue during the period after the deal closed on March 17, about one quarter earlier than previously assumed. Bank of America said IBM is likely to keep its full-year 2026 guidance unchanged, as management is expected to offset near-term dilution from the acquisition with a combination of additional revenue contribution and cost synergies.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Confluent, Inc. - CFLT
NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. (“Confluent” or the “Company”) (NASDAQ: CFLT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Capricorn Fund Managers Ltd Buys New Stake in Confluent, Inc. $CFLT
Capricorn Fund Managers Ltd purchased a new position in shares of Confluent, Inc. (NASDAQ: CFLT) during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 130,391 shares of the company's stock, valued at approximately $3,943,000. A number of other institutional investors have also modified
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Confluent, Inc. - CFLT
NEW YORK, April 2, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. ("Confluent" or the "Company") (NASDAQ: CFLT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Confluent, Inc. - CFLT
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. (“Confluent” or the “Company”) (NASDAQ: CFLT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Confluent, Inc. - CFLT
NEW YORK, March 26, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. ("Confluent" or the "Company") (NASDAQ: CFLT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Confluent, Inc. - CFLT
NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. (“Confluent” or the “Company”) (NASDAQ: CFLT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Confluent, Inc. (NASDAQ:CFLT) Receives Consensus Recommendation of “Hold” from Brokerages
Confluent, Inc. (NASDAQ: CFLT - Get Free Report) has been assigned an average rating of "Hold" from the thirty-three brokerages that are presently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, twenty-eight have issued a hold recommendation, three have assigned a buy recommendation and one has assigned a
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Confluent, Inc. - CFLT
NEW YORK, March 19, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. ("Confluent" or the "Company") (NASDAQ: CFLT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
IBM CEO Krishna on Confluent Deal, AI and Hiring
IBM CEO Arvind Krishna discusses the company's completion of its $11 billion acquisition of Confluent. Speaking with Caroline Hyde on "Bloomberg Open Interest," Krishna also says AI is a tailwind for the company and hasn't resulted in a net decrease in workers.
IBM Closes $11 Billion Deal for Confluent
Deal will help companies access their data for AI agents, says IBM CEO Arvind Krishna, as he brushes off AI's risk to IBM's business.
Bamco Inc. NY Sells 100,000 Shares of Confluent, Inc. $CFLT
Bamco Inc. NY lowered its holdings in Confluent, Inc. (NASDAQ: CFLT) by 60.6% in the undefined quarter, according to the company in its most recent filing with the SEC. The firm owned 65,000 shares of the company's stock after selling 100,000 shares during the quarter. Bamco Inc. NY's holdings in Confluent were worth
200,000 Shares in Confluent, Inc. $CFLT Acquired by Alight Capital Management LP
Alight Capital Management LP acquired a new stake in Confluent, Inc. (NASDAQ: CFLT) in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 200,000 shares of the company's stock, valued at approximately $3,960,000. Alight Capital Management LP owned approximately 0.06%
Price Targets
Confluent downgraded to Market Perform from Outperform at Bernstein
$31.00
(was $30.53)
Bernstein
Confluent price target raised to $31 from $26 at Baird
$31.00
(was $29.87)
William Power
·
Robert W. Baird
Confluent downgraded to Neutral from Buy at UBS
$31.00
(was $29.87)
UBS
Confluent downgraded to Sector Perform from Outperform at RBC Capital
$31.00
(was $29.87)
RBC Capital
Confluent downgraded to Neutral from Buy at DA Davidson
$31.00
(was $29.87)
D.A. Davidson
Confluent downgraded to Hold from Buy at Deutsche Bank
$31.00
(was $29.87)
Brad Zelnick
·
Deutsche Bank
Confluent downgraded to Hold from Buy at Canaccord
$31.00
(was $29.87)
Canaccord Genuity
Confluent downgraded to In Line from Outperform at Evercore ISI
$31.00
(was $29.93)
Evercore ISI
Confluent downgraded to Hold from Buy at Truist
$31.00
(was $29.86)
Miller Jump
·
Truist Financial
Confluent downgraded to Equal Weight from Overweight at Stephens
$31.00
(was $29.85)
Stephens
Confluent downgraded to Equal Weight from Overweight at Wells Fargo
$31.00
(was $29.85)
Wells Fargo
Confluent downgraded to Neutral from Overweight at Piper Sandler
$31.00
(was $29.73)
Piper Sandler
Guggenheim Reiterates Buy Rating on Confluent Inc (CFLT)
$29.00
(was $29.74)
Howard Ma
·
Guggenheim
DA Davidson Reiterates Buy Rating on Confluent Inc (CFLT)
$29.00
(was $23.41)
New Street
Confluent Inc (CFLT) PT Raised to $28 at FBN Securities
$28.00
(was $23.62)
Shebly Seyrafi
·
FBN Securities
Confluent price target raised to $29 from $28 at UBS
$29.00
(was $23.74)
Radi Sultan
·
UBS
Confluent price target raised to $29 from $27 at Truist
$29.00
(was $24.64)
Truist Financial
Confluent price target raised to $28 from $23 at Evercore ISI
$28.00
(was $24.42)
UBS
Confluent price target raised to $30 from $27 at RBC Capital
$30.00
(was $24.42)
RBC Capital
Confluent price target raised to $30 from $25 at Raymond James
$30.00
(was $24.64)
Mark Cash
·
Raymond James